In Person Seminar: Pathogenic Mechanisms and Novel Therapies for Immune Neoplasms
Ari Melnick, M.D.
Gebroe Family Professor of Hematology/Oncology
Department of Medicine
Director, Sackler Center for Biomedical and Physical Sciences
Weill Medical College
Cornell University
Pioneers in Biomedical Research Seminar: Pathogenic Mechanisms and Novel Therapies for Immune Neoplasms
Date: Feb. 10, 2023
Time: 11 a.m. - 12 p.m.
About this Seminar
A majority of hematologic malignancies arise from B-cells undergoing the adaptive immune response. Dr. Melnick will discuss recent insights explaining why this particular pathway is so prone to transformation and how B-cells arise from aberrant immune niches. He will also discuss some of the therapeutic vulnerabilities discovered based on mechanistic observations of the pathogenic trajectory of these tumors.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
In Person Seminar: Precision Medicine in Cardiac Electrophysiology , homeOct. 6, 2023, 11:00 a.m. | Jennifer Silva, M.D., Professor of Pediatrics and Pediatric Cardiology, Director of Pediatric Electrophysiology, Washington University School of Medicine in St. Louis; Jonathan Silva, Ph.D., Professor, Biomedical Engineering and Computer Science and Engineering, Washington University in St. Louis; and | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Cloudy with a Chance of Science: The Intersection of Wicked Problems, Perception, Communication, and Risk , homeOct. 19, 5:30 p.m. (Reception at 5 p.m.) | J. Marshall Shepherd, Ph.D., Georgia Athletic Association Distinguished Professor of Atmospheric Sciences and Geography, Director, UGA Atmospheric Sciences Program, University of Georgia, and Member, National Academy of Engineering, National Academy of Sciences, and American Academy of Arts and Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
In Person Seminar: Adolescent Alcohol, Behavioral Flexibility, and Excitatory/Inhibitory Balance in Control Circuitry , homeOct. 20, 2023, 11:00 a.m. | Charlotte Boettiger, Ph.D., Professor and Director, Behavioral and Integrative Neuroscience Program, Bowles Center for Alcohol Studies, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home Item
Learning and Relearning Movement , homeNov. 2, 5:30 p.m. (Reception at 5 p.m.) | Amy Bastian, Ph.D., Professor, Departments of Neuroscience and Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine; Chief Science Officer and Senior Vice President, Kennedy Krieger Institute; Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
In Person Seminar: Biobehavioral Synchrony and the Foundations of Resilience; From Science to Clinic , homeNov. 3, 2023, 11:00 a.m. | Ruth Feldman, Ph.D., Simms-Mann Professor of Developmental Social Neuroscience, Yale Child Study Center, Reichman University, Herzliya, Israel | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home Item
In Person Seminar: The Blood-Tumor Barrier: New Perspectives on Drug Delivery and Clinical Relevance , homeNov. 9, 2023, 11:00 a.m., Children's National Research and Innovation Campus, Washington, D.C. | Sadhana Jackson, M.D., Investigator, Developmental Therapeutics and Pharmacology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group